{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "OVB.L",
  "generated_at": "2026-01-17T11:51:32.727006Z",
  "top_card": {
    "ticker": "OVB.L",
    "company_name": "Ovoca Bio plc",
    "sector": "Healthcare",
    "market_cap_gbp": 9379,
    "days_active": 370,
    "apex_score_100": 48,
    "confidence_score_100": 25,
    "ai_final_score_25": 17,
    "ai_strength": "STRONG",
    "timing_regime": "BROKEN",
    "action": "AVOID",
    "thesis_one_liner": "AVOID - BROKEN timing with 48/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Ovoca Bio plc",
      "sector": "Healthcare",
      "industry": "Biotechnology",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 9379,
      "current_close_price": 0.0115
    },
    "basics": {
      "ticker": "OVB.L",
      "current_price": 0.0115,
      "ath": 26.0,
      "atl": 0.0115,
      "ath_date": "2022-02-23",
      "atl_date": "2025-05-08",
      "week_52_high": 1.674,
      "week_52_low": 0.0115,
      "week_52_high_date": "2025-01-16",
      "week_52_low_date": "2025-05-08",
      "drawdown_from_ath_pct": 99.96,
      "data_start": "2020-01-02",
      "data_end": "2026-01-15",
      "total_bars": 1525
    },
    "latest_signal": {
      "date": "2025-01-10",
      "scan_date": "2026-01-14",
      "signal_type": "ULTRA CRASH BOTTOM",
      "signal_color": "RED",
      "price": 0.016,
      "drawdown_pct": 99.19,
      "ai_score": 14.0,
      "rsi": 0.0,
      "cycle_position": 0.0005,
      "holding_period_days": 370,
      "current_pnl_pct": -28.12,
      "rally_state": "accumulating",
      "distance_from_high_pct": -99.28,
      "Rally_Count": 1,
      "days_since_last_high": 8,
      "last_high_date": "2026-01-06",
      "lock_in_reached": true,
      "lock_in_date": "2025-01-13",
      "best_rally_pct": 9900.0,
      "split_affected": true,
      "split_warning": "\u26a0\ufe0f",
      "warning_message": "Signal near stock split on 2025-01-10 (1:20)"
    },
    "best_historical_signal": {
      "signal_date": "2024-04-02",
      "signal_type": "EXTREME CRASH BOTTOM",
      "signal_color": "ORANGE",
      "entry_price": 0.6,
      "peak_price": 1.98,
      "peak_date": "2024-10-21",
      "rally_pct": 230.0,
      "days_to_peak": 202,
      "ai_score": 12.0
    },
    "all_historical_signals": [
      {
        "signal_id": "OVB.L_2022-12-13",
        "signal_date": "2022-12-13",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.75,
        "current_price": 0.0115,
        "current_return_pct": -99.76,
        "best_rally_pct": 194.74,
        "best_rally_date": "2023-08-29",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.92,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 1128,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2022-12-14",
        "signal_date": "2022-12-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.75,
        "current_price": 0.0115,
        "current_return_pct": -99.76,
        "best_rally_pct": 194.74,
        "best_rally_date": "2023-08-29",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.92,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 1127,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-08-31",
        "signal_date": "2023-08-31",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.75,
        "current_price": 0.0115,
        "current_return_pct": -99.58,
        "best_rally_pct": -12.73,
        "best_rally_date": "2023-09-01",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 867,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-09-01",
        "signal_date": "2023-09-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.4,
        "current_price": 0.0115,
        "current_return_pct": -99.52,
        "best_rally_pct": -6.25,
        "best_rally_date": "2023-09-04",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 866,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-09-06",
        "signal_date": "2023-09-06",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.25,
        "current_price": 0.0115,
        "current_return_pct": -99.49,
        "best_rally_pct": -4.44,
        "best_rally_date": "2023-09-07",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 861,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-05",
        "signal_date": "2023-10-05",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.4,
        "current_price": 0.0115,
        "current_return_pct": -99.18,
        "best_rally_pct": 37.14,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 832,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-06",
        "signal_date": "2023-10-06",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.475,
        "current_price": 0.0115,
        "current_return_pct": -99.22,
        "best_rally_pct": 30.17,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 831,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-10",
        "signal_date": "2023-10-10",
        "signal_type": "ENHANCED EXTREME CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.3,
        "current_price": 0.0115,
        "current_return_pct": -99.12,
        "best_rally_pct": 47.69,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 827,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-10-13",
        "signal_date": "2023-10-13",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.3,
        "current_price": 0.0115,
        "current_return_pct": -99.12,
        "best_rally_pct": 47.69,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 824,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-11-29",
        "signal_date": "2023-11-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.25,
        "current_price": 0.0115,
        "current_return_pct": -99.08,
        "best_rally_pct": 53.6,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 777,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-01",
        "signal_date": "2023-12-01",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.15,
        "current_price": 0.0115,
        "current_return_pct": -99.0,
        "best_rally_pct": 66.96,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 775,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-05",
        "signal_date": "2023-12-05",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.15,
        "current_price": 0.0115,
        "current_return_pct": -99.0,
        "best_rally_pct": 66.96,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 771,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-07",
        "signal_date": "2023-12-07",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.05,
        "current_price": 0.0115,
        "current_return_pct": -98.9,
        "best_rally_pct": 82.86,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 769,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-21",
        "signal_date": "2023-12-21",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 755,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-22",
        "signal_date": "2023-12-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 754,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2023-12-27",
        "signal_date": "2023-12-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.9,
        "current_price": 0.0115,
        "current_return_pct": -98.72,
        "best_rally_pct": 113.33,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 749,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-01-04",
        "signal_date": "2024-01-04",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.825,
        "current_price": 0.0115,
        "current_return_pct": -98.61,
        "best_rally_pct": 132.73,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 741,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-02-29",
        "signal_date": "2024-02-29",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.8,
        "current_price": 0.0115,
        "current_return_pct": -98.56,
        "best_rally_pct": 140.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 685,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-03-26",
        "signal_date": "2024-03-26",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.7,
        "current_price": 0.0115,
        "current_return_pct": -98.36,
        "best_rally_pct": 174.29,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 659,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-04-02",
        "signal_date": "2024-04-02",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.6,
        "current_price": 0.0115,
        "current_return_pct": -98.08,
        "best_rally_pct": 220.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 652,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-04-03",
        "signal_date": "2024-04-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.6,
        "current_price": 0.0115,
        "current_return_pct": -98.08,
        "best_rally_pct": 220.0,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 651,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-07-01",
        "signal_date": "2024-07-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.775,
        "current_price": 0.0115,
        "current_return_pct": -98.52,
        "best_rally_pct": 147.74,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 562,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2024-08-28",
        "signal_date": "2024-08-28",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.725,
        "current_price": 0.0115,
        "current_return_pct": -98.41,
        "best_rally_pct": 164.83,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.4,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 504,
        "status": "historical"
      },
      {
        "signal_id": "OVB.L_2025-01-10",
        "signal_date": "2025-01-10",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.016,
        "current_price": 0.0115,
        "current_return_pct": -28.12,
        "best_rally_pct": 9900.0,
        "best_rally_date": "2025-01-13",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.28,
        "days_since_last_high": 8,
        "lock_in_reached": true,
        "age_days": 369,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 24,
      "win_rate_pct": 95.8,
      "avg_rally_pct": 537.01,
      "median_rally_pct": 120.0,
      "best_rally_pct": 10362.5,
      "worst_rally_pct": -3.27
    },
    "splits": [
      {
        "date": "2025-01-10",
        "ratio": "1:20",
        "ratio_value": 100.0
      },
      {
        "date": "2025-05-08",
        "ratio": "1:20",
        "ratio_value": 100.0
      }
    ],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "SUSPECT",
      "pnl_reliability": "SUSPECT",
      "overall_confidence": "LOW"
    },
    "risk_flags": [
      "SIGNAL_NEAR_SPLIT",
      "HAS_REVERSE_SPLIT",
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-01-17 01:26:42 UTC",
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "trends": {
      "intelligence_signal": "ACCUMULATION"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 48/100 indicates moderate opportunity quality",
      "Timing regime: BROKEN",
      "Historical profile: 1 rallies, 9900% best run"
    ],
    "main_risk": "Confidence 25/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "OVB.L",
      "latest": [
        {
          "title": "Sale of Treasury Shares",
          "announcement_date": "9th Oct 2024",
          "release_time": "5:45 pm",
          "source": "RNS",
          "content": "9 Oct 2024 17:45\nRNS Number : 6081H\nOvoca Bio PLC\n09 October 2024\nOvoca Bio plc\n(\"Ovoca\" or the \"Company\")\nSale of Treasury Shares\nDublin, Ireland, 9 October 2024 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, announces that it has transferred 6,895,000 ordinary shares of the Company out of treasury (\"Treasury Shares\"), and sold these shares in the market at an average price of approximately 1.01 pence per share, raising gross proceeds of \u00a369,020.\nFollowing the sale of the Treasury Shares, the Company has a total of 88,458,806 ordinary shares in issue, and there are no remaining shares held in treasury. Therefore, the figure of 88,458,806 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.\nEnd\nFor further information:\nOvoca Bio plc\nTim McCutcheon (Chief Executive Officer)\nTel +353 1 661 9819\ninfo@ovocabio.com\nDavy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)\nIvan Murphy / Daragh O'Reilly\nTel: +353 1 679 6363\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nDISFZMGGVLFGDZM"
        },
        {
          "title": "Disposal of Russian Assets",
          "announcement_date": "8th Mar 2023",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "8 Mar 2023 07:00\nRNS Number : 1981S\nOvoca Bio PLC\n08 March 2023\nOvoca Bio plc\n(\"Ovoca\" or the \"Company\")\nDisposal of Russian Assets\nDublin, Ireland, 8 March 2023\n- Ovoca Bio, a biopharmaceutical company with a focus on women's health, today announces that it has agreed the disposal of certain Russian assets to Desirix LLC, a private Russian company, for a cash consideration of 84.6 million Russian rubles (approximately \u20ac1.05 million at the current exchange rate1)(the \"Disposal\"). Pursuant to the Disposal, Ovoca has agreed to sell certain Russian assets related to its clinical development product Orenetide, namely the Russian patents for Orenetide, the results of completed scientific development of Orenetide in Russia, together with the right to own a Russian Marketing Authorization for Orenetide in Russia.\nOvoca expects the Disposal to complete by 31 March 2023. Upon completion of the Disposal, all operational activities of Ovoca in Russia will cease and Ovoca's Russian\nsubsidiary, IVIX LLC (\"IVIX\")\nwill be transferred to an inactive, non-operating status. The proceeds from the Disposal will be used for general corporate purposes.\nBackground and rationale for the Disposal\nAs a consequence of the Russia-Ukraine conflict and subsequent international sanctions imposed on the Russian economy and financial system, the Board of Ovoca has concluded that there is no longer any practical opportunity for Ovoca to further invest in, nor conduct normal operations and generate income for shareholders from operating in Russia. In addition, the continuation of business in Russia may carry reputational and legal risks for the entire Company.\nHaving considered the options available to it with regards to its Russian operations and taking into account the constraints under which it would be required to operate, such as the current sanctions environment, the Board has concluded that the best course of action for Ovoca is to proceed with the Disposal and sell the Company's assets in Russia and thereby cease operating in Russia.\nFollowing completion of the Disposal, Ovoca will continue with its current clinical development plans for Orenetide in major global markets. This includes the Company's Phase II dose ranging study of Orenetide being conducted in Australia and New Zealand. As previously noted, all enrolled participants have completed the designated course of treatment and Ovoca expects data from the study to become available during the first half of 2023. The Phase II study will provide data in a Western population fully compliant with the standards of the International Conference on Harmonisation that, if successful, will ultimately support a clinical programme in the US and EU.\nKirill Golovanov, Chief Executive Officer of Ovoca Bio plc, said:\n\"Regretfully, it has proved increasingly difficult to continue Ovoca's operations in Russia under the current constraints and this has led us to conclude that a disposal of our Russian assets is the correct course of action for the wider business.\nHowever, we are optimistic about further increasing the value of our global assets associated with Orenetide as a potential treatment for hypoactive sexual desire disorder in wider international markets, including the US and EU. We look forward to providing further updates in due course.\"\nAdditional Information\nAs at 1 December 2022 the\nNet Book Value for Development Costs\nof Orenetide in Russia\nwithin\nIVIX was 47.8\nmillion Russian rubles (approximately \u20ac0.60 million1), and Russian patents for Orenetide were independently valued at 25.1 million Russian rubles (approximately \u20ac0.31 million1).\n1\nConverted at FX rate of 80.24 RUB/EUR as at 7 March 2023\nEnd\nFor further information:\nOvoca Bio plc\nKirill Golovanov (Chief Executive)\nTel +353 1 661 9819\ninfo@ovocabio.com\nDavy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)\nIvan Murphy / Daragh O'Reilly\nTel: +353 1 679 6363\nAbout Ovoca Bio\nOvoca Bio is a European-based biopharmaceutical company with a focus on women's health. The Company is currently developing a novel treatment for women with hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack or loss of sexual desire affecting an estimated ~4 million premenopausal women in the US alone.\nThe Company's lead product, Orenetide (BP-101), a novel synthetic peptide administered through a nasal spray, is clinically validated, with regional Phase II and Phase III studies conducted in Russia demonstrating statistically significant improvement in a number of key efficacy outcomes, including an increase in female sexual desire and reduction of symptoms of distress associated with HSDD.\nOvoca Bio is seeking to develop the drug for major global markets - in particular the United States and Europe.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nDISEAKDXELADEFA"
        },
        {
          "title": "Notice of AGM",
          "announcement_date": "7th Nov 2023",
          "release_time": "9:15 am",
          "source": "RNS",
          "content": "7 Nov 2023 09:15\nRNS Number : 6350S\nOvoca Bio PLC\n07 November 2023\nOvoca Bio plc\n(\"Ovoca\" or the \"Company\")\nNotice of AGM\nDublin, Ireland, November\n7\n, 2023 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, announces that a\nNotice of Annual General Meeting (\"AGM\"), containing details of the resolutions to be proposed at the AGM, has been published and posted to shareholders. The Notice of AGM is also available on the Company's website at\nhttps://ovocabio.com/agm-registration/\n.\nThe Company's 2023 AGM will be held via live conference facility on 30 November 2023 at 4 p.m. Further details in relation to shareholder participation in the meeting is detailed in the Notice of AGM.\nIt will be possible to fully participate in the meeting using the live conferencing facility provided by the Company for this purpose. Shareholders will be able to use this facility to vote and /or ask questions. Shareholders will also be able to submit questions in advance of the AGM in writing by email to the Company Secretary at info@ovocabio.com to be received no later than 4 p.m. on 28 November 2023. All correspondence should include sufficient information to identify the shareholder on the Register of Members. Questions submitted using these methods will be addressed by the Chairman at the AGM, where possible.\nEnd\nFor further information:\nOvoca Bio plc\nKirill Golovanov (Chief Executive)\nTel +353 1 661 9819\ninfo@ovocabio.com\nDavy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)\nIvan Murphy / Daragh O'Reilly\nTel: +353 1 679 6363\nAbout Ovoca Bio\nOvoca Bio is a European-based biopharmaceutical company with a focus on women's health. The Company is currently developing Orenetide (BP-101), a novel synthetic peptide administered through a nasal spray as a novel treatment for women with hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack or loss of sexual desire affecting an estimated ~4 million premenopausal women in the US alone.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNOAGIBDBRUGDGXR"
        },
        {
          "title": "Suspension - Ovoca Bio plc",
          "announcement_date": "7th May 2025",
          "release_time": "7:30 am",
          "source": "RNS",
          "content": "7 May 2025 07:30\nRNS Number : 5548H\nAIM\n07 May 2025\nNOTICE\n07/05/2025 7:30am\nTEMPORARY SUSPENSION OF TRADING ON AIM\nOVOCA BIO PLC\nAt the request of the company, trading on AIM for the under-mentioned securities has been temporarily suspended from 07/05/2025 7:30am, pending an announcement and publication of an admission document.\nORDINARY SHARES OF EUR0.125 EACH, FULLY PAID (CDI)\n(B5641B8) (IE00B4XVDC01)\nIf you have any queries relating to the above, please contact the company's nominated adviser on +44 (0) 207 628 3396\n.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nEXCAFMATMTIMBTA"
        },
        {
          "title": "Proposed Acquisition, Disposal & Reverse Takeover",
          "announcement_date": "7th May 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "7 May 2025 07:00\nRNS Number : 5676H\nOvoca Bio PLC\n07 May 2025\nOvoca Bio PLC\n7 May 2025\nOvoca Bio plc\n(\"Ovoca\" or the \"Company\")\nProposed Acquisition, Disposal and Reverse Takeover\nChange of Financial and Nominated Adviser and Broker\nCorporate Changes\nand\nProposed Cancellation of Admission to Trading on Euronext Growth\nProposed Acquisition\nOvoca is pleased to announce it has entered into a conditional Letter of Intent (\"LOI\") to acquire 100% of Tadeen International Limited (\"Tadeen\"), a UK-registered company, which indirectly owns 100% of a portfolio of mineral exploration licenses in Morocco prospective for Copper and Silver (the \"Proposed Acquisition\").\nThe Proposed Acquisition will constitute a reverse takeover (\"RTO\") under the AIM Rules for Companies (the \"AIM Rules\") as, inter alia, the consideration for the Proposed Acquisition is larger than the Company's current market capitalization, as well as constituting a fundamental change in the Company's business and therefore, in accordance with Rule 14 of the AIM Rules, will require application to be made for the enlarged share capital to be readmitted to AIM (\"Admission\"), the publication of an AIM admission document (\"Admission Document\") and approval by the shareholders of the Company at a general meeting.\nOvoca has appointed Beaumont Cornish Limited as its new Financial and Nominated Adviser, or \"Nomad\" to lead the RTO and re-admission to AIM of the enlarged group as well as its Broker.\nSummary of acquisition terms:\n\u00b7\nTadeen is a company incorporated under the laws of England and Wales, with its principal asset consisting of its 100% interest in Horizon Mines S.A.R.L, a company registered and incorporated in the Kingdom of Morocco, who hold the portfolio of mineral exploration licenses;\n\u00b7\nPursuant to the Proposed Acquisition, Ovoca will acquire all of the issued Ordinary Shares of Tadeen together with Tadeen's debts and liabilities in exchange for the ordinary shares in the capital of Ovoca (the \"Ovoca Ordinary Shares\"), resulting in a takeover by Ovoca of Tadeen;\n\u00b7\nIt is intended that the current shareholders and creditors of Tadeen will receive an aggregate maximum of US$1,535,715 (\"Consideration\") in the form of Ovoca Ordinary Shares;\n\u00b7\nConcurrent to closing of the RTO, if considered reasonable to be done, Ovoca will do a three for one share consolidation of the outstanding Ovoca Ordinary Shares;\n\u00b7\nFollowing the Proposed Acquisition and completion of the RTO the enlarged group will be renamed \"Talisman Metals plc\" or such other name as by may determined by Ovoca, to align the with the future business strategy and operations of the Company going forward; and\n\u00b7\nThe LOI contains a number of conditions including completion of mutual satisfactory due diligence, compliance with all regulatory requirements, the entering into of an agreeable Definitive Agreement (\"SPA) along with other standard terms.\nThe Company expects to undertake a fundraise in connection with the RTO. Should the Acquisition be completed, it is anticipated that Tadeen shareholders would own approximately 40% of the enlarged issued share capital of the group on Admission. Ovoca and the shareholders of Tadeen expect to agree to the terms of a binding Share Purchase Agreement (\"SPA\") in Q2 2025.\nThe LOI is not currently binding and there is no certainty that the proposed Acquisition will be completed. A further announcement will be made when appropriate.\nShould the\nP\nroposed\nA\ncquisition proceed, approval of shareholders of the Company in a general meeting will be required. As such, a further announcement with full details of the transaction would be issued at the appropriate time once binding contracts are entered into and an admission document published and sent to shareholders with a notice of general meeting.\nIn accordance with the AIM Rules for Companies and the Euronext Growth Dublin Rules, the Company's shares will be suspended from trading on AIM and Euronext with effect from\n7.30\na.m.. today. The Company's ordinary shares will remain suspended until such time as either an admission document is published or an announcement is released confirming that the transaction is not proceeding.\nThe Irish Takeover Panel will be consulted in due course regarding the requirement or otherwise for the Company to seek a Rule 9 Waiver pursuant to Appendix 1 of the Irish Takeover Code in respect of certain vendors of the Acquisition holding 30% or more as a result of the Proposed Acquisition.\nSummary of disposal of Company's Operating Assets\nAt the same time, Ovoca announces that it has now sold for a nominal sum to an unconnected third party, its wholly-owned subsidiary Silver Star Limited (\"Silver Star\"), which owns 100% of IVIX LLC, thereby, given the Board's recent decision to allow the\nOrenetide\nand related patents to lapse,\ncompletely exiting the biopharmaceutical business, which had been its core business. In 2023, as recorded in the Company's audited annual financial accounts, the value of IVIX was written down to zero after unsuccessful Phase II trials (see RNS dated 31 August 2023). This only leaves the Company with its dormant Australian subsidiary which it expects to wind up in the next 12 months. As such, the Company, in ceasing any of its former\nbiopharmaceutical\ndevelopment activities and retaining no biopharmaceutical Intellectual Property, will,\nwith immediate effect, becom\ne\nan AIM Rule 15 cash shell. As an AIM Rule 15 cash shell the Company will have six months to make an acquisition or acquisitions which constitutes a reverse takeover under AIM Rule 14.\nThe Company and Tadeen are committed to completing the RTO during which time the Company will remain suspended on AIM. The Company has sufficient cash resources to fund all ongoing working capital costs, IPO Admission costs and all other expenses until re-Admission, at which point there will be a Company lead Subscription and UK Broker Placing as part of the RTO Fundraise to execute the 18-month exploration work program and other ongoing corporate overheads.\nProposed Cancellation of Admission to Trading on Euronext Growth\nThe Company also today announces its intention to cancel its admission to trading on Euronext Growth (the \"Cancellation\"). In anticipation of progressing with the Proposed Acquisition, the Board has decided to consolidate trading of the Company's ordinary shares to the AIM Market of the London Stock Exchange, where the majority of the trading liquidity in the Company's Ordinary Shares is currently located. The Cancellation will also remove certain costs, complexities and duplication that comes from administering two listing regimes and will have no impact on Ovoca's Ordinary Shares which will continue to be admitted to AIM.\nIn accordance with the Euronext Growth Rules, the Company has notified Euronext of the proposed Cancellation. Under the Euronext Growth Rules, the Cancellation can only take place after the expiry of a minimum period of twenty Business Days from the date on which notice of the Cancellation is given. Accordingly, it is intended that the Cancellation will become effective at 7.00 a.m. on 5 June 2025.\nCorporate Matters\nThe Company also expects to shortly conclude the Taymura litigation as previously outlined in the 2023 Annual Report & Accounts.\nFurthermore, Ovoca's non-executive director Kristina Zakurdaeva, has resigned as a director effective today. The Company thanks her for her service and wishes her well in her future endeavors. The Board expects to appoint additional directors as part of the RTO.\nAs mentioned, Ovoca has appointed Beaumont Cornish Limited as its new Financial and Nominated Adviser, or \"Nomad\" and Broker with effect from today. The Company thanks its previous nominated adviser Davy for its tenure with the Company over many years.\nComment from CEO\nTimothy McCutcheon, Ovoca's CEO, said \"I am very excited about this proposed acquisition and RTO as contemplated, and the Board believes the enlarged group's business strategy and highly prospective exploration interests in Morocco offer existing and future investors the potential to realize significant shareholder gains.\"\nEnd\nFor further information:\nOvoca Bio plc\nTimothy McCutcheon (Chief Executive Officer)\nTel +353 1 661 9819\ninfo@ovocabio.com\nBeaumont Cornish Limited (Nominated Adviser and Broker)\nJames Biddle/ Roland Cornish\nTel: +44 (0) 207 628 3396\nDavy (Euronext Growth Listing Sponsor)\nIvan Murphy / Daragh O'Reilly\nTel: +353 1 679 6363\nThe information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.\nBeaumont Cornish Limited (\"Beaumont Cornish\") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCPKABNABKDAPK"
        }
      ],
      "themes": []
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 125,
      "sentiment_breakdown": {
        "positive": 0.8,
        "neutral": 98.4,
        "negative": 0.8
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "ACCUMULATION"
    },
    "volatility": {
      "atr_normalized": 10.0,
      "stddev_20d": 0.0
    },
    "risk_flags": {
      "split_risk_level": "HIGH",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2025-01-13"
    }
  },
  "ai_insights": {
    "available": false,
    "reason": "LLM module not loaded or analysis failed"
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "INDUSTRIALS",
      "name": "Industrials",
      "icon": "\ud83c\udfed",
      "color": "#64748b",
      "crash_patterns": [
        "Order book decline or cancellations",
        "Margin compression (input costs)",
        "Cyclical demand weakness",
        "Project delays or overruns",
        "Working capital strain"
      ],
      "recovery_paths": [
        "Order book growth or new contracts",
        "Margin recovery (efficiency gains)",
        "Cyclical upturn (capex recovery)",
        "M&A consolidation",
        "Product innovation or new markets"
      ],
      "active_patterns": [],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Order book value (forward revenue)",
        "Book-to-bill ratio",
        "Operating margin trends",
        "Working capital efficiency",
        "Capex cycles (customer industries)"
      ]
    },
    "panic_analysis": {
      "panic_score": 62,
      "signal": "HIGH_PANIC",
      "interpretation": "\ud83d\udfe0 Fear dominant - watch for reversal signs",
      "breakdown": {
        "price_destruction": 40,
        "volume_death": 14,
        "social_silence": 6,
        "news_sentiment": 2
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 40/40 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 9900% proven capacity",
        "\ud83d\udcb0 Deep value: 28% off recent peak"
      ],
      "verdict": "\u2705 Facts align with low fear - Normal risk/reward"
    },
    "crashhunter_signals": [
      {
        "type": "HIGH_PANIC",
        "icon": "\ud83d\udfe0",
        "text": "Fear 62/100",
        "color": "#f59e0b"
      },
      {
        "type": "BROKEN",
        "icon": "\u274c",
        "text": "Broken",
        "color": "#ef4444"
      },
      {
        "type": "LOW_DATA",
        "icon": "\u2753",
        "text": "Conf 25",
        "color": "#64748b"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Sale of Treasury Shares",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Disposal of Russian Assets",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Notice of AGM",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Suspension - Ovoca Bio plc",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Proposed Acquisition, Disposal & Reverse Takeover",
        "status": "published",
        "icon": "\ud83d\udce2"
      }
    ],
    "decision_matrix": {
      "decision": "AVOID",
      "reason": "\u274c AVOID - timing BROKEN",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "62/100",
          "pass": true,
          "icon": "\ud83d\udd34"
        },
        {
          "criterion": "Timing Regime",
          "value": "BROKEN",
          "pass": false,
          "icon": "\u274c"
        },
        {
          "criterion": "APEX Quality",
          "value": "48/100",
          "pass": false,
          "icon": "\u26a0\ufe0f"
        },
        {
          "criterion": "Data Confidence",
          "value": "25/100",
          "pass": false,
          "icon": "\u2753"
        },
        {
          "criterion": "Industry Pattern",
          "value": "0 active",
          "pass": true,
          "icon": "\ud83c\udfed"
        }
      ],
      "pass_rate": "2/5"
    },
    "contrarian_panic": {
      "total_score": 47,
      "band": "\ud83d\udfe1 MODERATE COMPRESSION (Top 30% - GOOD SETUP)",
      "components": {
        "compression": {
          "score": 7,
          "max": 40,
          "signals_30d": 1,
          "signals_60d": 1,
          "signals_90d": 1,
          "signals_per_week": 0.08,
          "total_signals": 24,
          "rsi_extreme_count": 1,
          "rsi_ultra_count": 1,
          "escalation_count": 0,
          "density_score": 3,
          "rsi_score": 4,
          "escalation_score": 0,
          "description": "0.1 signals/week | 1 RSI<20 | Early stage"
        },
        "intensification": {
          "score": 20,
          "max": 20,
          "recent_types": [
            "CRASH ZONE BOTTOM",
            "EXTREME CRASH BOTTOM",
            "ULTRA CRASH BOTTOM"
          ],
          "escalating": true,
          "sustained": false,
          "current_intensity": 4,
          "pattern": "ESCALATING TO EXTREME - Fear building!"
        },
        "volume_death": {
          "score": 5,
          "max": 15,
          "relative_volume": 2.94,
          "description": "Elevated volume - Some activity"
        },
        "pop_potential": {
          "score": 15,
          "max": 15,
          "best_historical_rally": 9900.0,
          "avg_rally": 509.9,
          "signal_count": 24,
          "description": "MONSTER POPPER - Historical 10x+ (9900%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation"
        }
      },
      "ticker": "OVB.L",
      "signal_date": "2025-01-10",
      "total_signals_history": 24
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +18 (AI_Technical_Score=14.0/20)",
      "Drawdown reversion potential: +20 (Drawdown_Pct=99.2%)",
      "Volume confirmation: +10 (Relative_Volume=2.9)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +20 (best_rally_pct=9900%)",
      "Split risk penalty: -15 (HIGH, age_factor=1.00)",
      "Recent exhaustion: -10 (best_rally=9900%, days_since_high=8.0)"
    ],
    "technical_score": {
      "points": 18,
      "ai_score": 14.0,
      "reason": "AI Technical Score 14.0/20 translates to 18/25 points"
    },
    "drawdown_score": {
      "points": 20,
      "drawdown_pct": 99.19,
      "reason": "Drawdown of 99.2% gives 20/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.94,
      "reason": "Relative volume 2.94x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 20,
      "best_rally_pct": 9900.0,
      "reason": "Best rally of 9900% gives 20/20 points"
    },
    "penalties": {
      "total": -25,
      "items": [
        "Split risk penalty: -15 (HIGH, age_factor=1.00)",
        "Recent exhaustion: -10 (best_rally=9900%, days_since_high=8.0)"
      ]
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Historically strong runner - massive upside when it moves",
        "tag": "HIGH",
        "evidence": [
          "best_rally_pct=9900%",
          "Rally_Count=1.0"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Split risk HIGH - price integrity compromised",
        "tag": "HIGH",
        "evidence": [
          "split_risk_level=HIGH"
        ]
      },
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2025-01-10"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Avoid",
      "action": "Do not trade - thesis invalidated",
      "sizing": "0%",
      "risk": "N/A",
      "profit_taking": "N/A"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "BROKEN",
    "run_multiple": -0.0,
    "current_run_pct": -28.12,
    "avg_historical_run_pct": 9900.0
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows BROKEN timing with 48/100 APEX score. Historical data shows 1 rallies averaging 9900% upside. Current position: -28.1%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Strong historical rally behavior (9900% best run)"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Thesis invalidated. Avoid or exit.",
    "confidence_explained": "Confidence 25/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": false
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}